News & Media

Recent News

Press Releases

SalioGen Therapeutics Closes $115 Million Oversubscribed Series B Financing to Advance Gene CodingTM – A New Category of Genetic Medicine

SalioGen Therapeutics Appoints Esteemed Industry Veterans to Executive Advisory Board

SalioGen Therapeutics Strengthens Management with Key Additions to Leadership Team to Advance Its Gene Coding Platform

SalioGen Therapeutics Announces Closing of $20 Million Series A Financing to Support Advancing a Novel Genome Engineering Platform for Non-Viral Gene Therapy

Media

Gene Cargos: Building A Bigger Ship

Genetic medicine: the next generation

Win The CGT Talent Fight: How To Find And Retain Experts

SalioGen: genome editing without viruses or nucleases (Subscription Required)

Lipid Nanoparticle Gene Coding With SalioGen Therapeutics’ Ray Tabibiazar, M.D.

An Interview with Ray Tabibiazar, M.D., CEO & Chairman of SalioGen Therapeutics